Crystal structure of a single-chain trimer of human adiponectin globular domain  by Min, Xiaoshan et al.
FEBS Letters 586 (2012) 912–917journal homepage: www.FEBSLetters .orgCrystal structure of a single-chain trimer of human adiponectin globular domain
Xiaoshan Min a, Bryan Lemon b, Jie Tang b, Qiang Liu b, Richard Zhang b, Nigel Walker a, Yang Li c,
Zhulun Wang a,⇑
aDepartment of Molecular Structure, Amgen Inc., 1120 Veterans Blvd., South San Francisco, CA 94080, USA
bDepartment of Protein Science, Amgen Inc., 1120 Veterans Blvd., South San Francisco, CA 94080, USA
cDepartment of Metabolic Disorders, Amgen Inc., 1120 Veterans Blvd., South San Francisco, CA 94080, USA
a r t i c l e i n f oArticle history:
Received 3 November 2011
Revised 11 January 2012
Accepted 15 February 2012
Available online 22 February 2012
Edited by Laszlo Nagy
Keywords:
X-ray crystal structure
Adiponectin
Single-chain globular domain
Calcium binding0014-5793/$36.00  2012 Federation of European Bio
doi:10.1016/j.febslet.2012.02.024
Abbreviations: ACRP30, adipocyte complement-rela
50-AMP-activated protein kinase; CHO, Chinese hams
glycol; ob/ob, obese mouse
⇑ Corresponding author. Fax: +1 650 837 9437.
E-mail address: zwang@amgen.com (Z. Wang).a b s t r a c t
Adiponectin is increasingly recognized as a potential therapeutic agent for the treatment of diabe-
tes and other metabolic diseases. It circulates in plasma as homotrimers and higher-order oliogo-
mers of homotrimers. To facilitate the production of active recombinant adiponectin as a
therapeutic tool, we designed a single-chain globular domain adiponectin (sc-gAd) in which three
monomer sequences are linked together in tandem to form one contiguous polypeptide. Here,
we present the crystal structure of human sc-gAd at 2.0 Å resolution. The structure reveals a similar
trimeric topology to that of mouse gAd protein. Trimer formation is further rigidiﬁed by three
calcium ions.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Adiponectin is an adipose tissue-speciﬁc protein hormone that
regulates whole body metabolism and energy homeostasis [1–4].
Exclusively expressed and secreted by adipocytes, adiponectin is
the most abundant adipokine with its serum concentration ranging
from 5 to 30 lg/mL. Adiponectin knockout mice exhibited insulin
resistance and glucose intolerance, while transgenic rodents
over-expressing adiponectin showed improved insulin sensitivity
and suppressed endogenous glucose production [5–8]. In humans,
the serum level of adiponectin is signiﬁcantly reduced in obese or
type II diabetic patients [9–11]. This negative correlation between
plasma adiponectin level and insulin resistance has made adipo-
nectin an attractive potential therapeutic tool for type II diabetes,
obesity and other metabolic diseases.
Adiponectin, also known as GBP28, apM1, AdipoQ and ACRP30,
is structurally related to the complement factor C1q family, and
collagen VIII and X proteins [12–15]. The primary sequence of
adiponectin consists of a short amino-terminal signal sequence, a
collagen-like domain and a carboxyl-terminal globular domainchemical Societies. Published by E
ted protein of 30 kDa; AMPK,
ter ovary; PEG, polyethylene(Fig. 1B). Like other C1q members, adiponectin multimerizes and
circulates in plasma as a homotrimer and its higher-order com-
plexes [16,17]. Oligomerization of adiponectin has been reported
to be important for its biological functions [17,18].
Most research efforts have focused on the C-terminal globular
domain of adiponectin (gAd) due to difﬁculties in expressing active
multimeric full length protein. Administration of gAd in rodent
models resulted in increased glucose uptake and fat oxidation in
muscle, and improved insulin sensitivity [19,20]. To further over-
come the manufacturability hurdle of generating homogeneous
active human gAd, we designed a novel protein construct suitable
for recombinant production by linking three gAd monomers
together in tandem to produce a single-chain globular domain
adiponectin (sc-gAd) [21]. This sc-gAd protein was successfully
produced recombinantly in mammalian cells and its Fc-fusion
form lowered plasma glucose levels and improved insulin sensitiv-
ity in ob/ob mice [21].
Here, we report the structural characterization of this human
sc-gAd by solving its X-ray crystal structure to a resolution of
2.0 Å. To our knowledge, no structural data has been reported pre-
viously for human adiponectin. The human sc-gAd adopts a similar
trimeric 10-strand jelly-roll fold, typical of the C1q family mem-
bers. Three calcium ions were identiﬁed at the apex region of the
protein, which helps to rigidify the entire apical loops, leading to
a tightly packed trimer for sc-gAd.lsevier B.V. All rights reserved.
Fig. 1. Design of human sc-gAd. (A) base region of mouse gAd structure (PDB code:
1C3H). One gAd monomer is shown in spectrum color scheme with blue for the N-
terminus of the sequence which transits to red for the C-terminus. The other two
gAd monomers are shown in single color with blue and red to denote the N- and C-
termini, respectively. (B) domain organization of human adiponectin and the sc-gAd
construct design used in this study. For sc-gAd, the three globular domains (A, B and
C) are shown in magenta, yellow and cyan, respectively. The ﬁrst and last residues
of individual domains are labeled.
Table 1
Statistics of crystallographic data and reﬁnement.
Data collection
Space group P1
Unit cell dimensions (Å) a = 48.06, b = 49.45, c = 50.22
a = 117.25, b = 101.83, c = 105.19
Wavelength (Å) 1.000
Resolution (Å) 42.5–2.0 (2.06–2.0)
No. of total reﬂections 89630
No. of unique 23623
Average multiplicity 3.79(3.54)
Completeness (%) 94.3(67.6)
Intensity I/r 7.5(3.3)
Rsym
a 0.083(0.250)
Reﬁnement
Rwork/Rfreeb 0.199/0.257
r.m.s.d in bond length (Å)c 0.010
r.m.s.d in bond angles ()c 1.51
Values in parentheses are for the highest resolution shell.
a Rsym ¼
P jIavg  Ijj=
P
Ij , where Ii is the observed intensity for the ith mea-
surement and Iavg is the average intensity of all measurements.
b Rfactor ¼
P jFo  Fcj=
P
Fo, where Fo and Fc are observed and calculated struc-
ture factors, respectively, Rfree was calculated from a randomly chosen 5% of
reﬂections excluded from the reﬁnement, and Rfactor was calculated from the
remaining 95% of reﬂections.
c r.m.s.d is the root-mean-square deviation from ideal geometry.
X. Min et al. / FEBS Letters 586 (2012) 912–917 9132. Materials and methods
2.1. Protein expression and puriﬁcation
DNA construct design, protein expression and puriﬁcation were
carried out as previously described [21]. Brieﬂy, three copies of hu-
man adiponectin globular domain sequences (Pro104–Asn244) in
tandem following a 6xHis tag were inserted into a mammalian
expression vector, stably integrated and expressed in CHO cells.
Conditioned media from CHO cells expressing the human sc-gAd
were concentrated and diaﬁltered against buffered saline at neu-
tral pH. The protein was puriﬁed by Ni-afﬁnity, anion-exchange
and size exclusion chromatography.
2.2. Protein crystallization
Puriﬁed sc-gAd was concentrated to 5 mg/mL in 20 mM Bis–
Tris–propane, pH 7.0, and 20 mM NaCl. The protein was crystal-
lized by mixing with 20% PEG3350, 0.1 M Bis–Tris, pH 5.5, in a
1:1 ratio by sitting drop method at 20 C. The crystals were trans-
ferred to a cryo-protection solution of 22% PEG3350, 0.1 M Bis–
Tris, pH 5.5 and 25% PEG200, and ﬂash frozen in liquid nitrogen.2.3. Data collection and structure determination
A 2.0 Å X-ray diffraction data set was collected on beamline
5.0.2 at the Advanced Light Source (ALS) (Berkeley, CA). The data
set was processed with d⁄TREK 97 [22]. The structure was solved
by the molecular replacement method using Phaser in CCP4 with
the mouse ACRP30 structure (PDB code: 1C28) as a search model
[23,24]. Model building and reﬁnement were carried out using
Coot [25] and Refmac5 [26], respectively. The ﬁnal R and Rfree fac-
tors are 19.9% and 25.7%, respectively. All ﬁgures were prepared
with Pymol [27].
3. Results
3.1. The overall structure of sc-gAd
The crystal structure of mouse adiponectin gAd (PDB code:
1C3H) revealed a trimeric assembly, with the N- and C-termini of
all three monomers positioned at the base region of the trimer.
Furthermore, the N-terminus of one monomer is in close proximity
to the C-terminus of the adjacent monomer with an approximate
distance of 11 Å (Fig. 1A). Based on this feature, we designed a sin-
gle-chain trimer of the globular domain of human adiponectin by
directly joining the C- and N-terminal residues between two adja-
cent monomers (Fig. 1B) [21]. Each monomer encompasses resi-
dues Pro104 to Asn244, in which residues Pro104 to Tyr109
(presumably ﬂexible due to the absence of the corresponding res-
idues in the mouse structure) serve as a natural linker between
two monomers. Crystals were grown from recombinant human
sc-gAd protein expressed in mammalian cells. The structure has
been determined to a resolution of 2.0 Å in the P1 space group with
one sc-gAd in the asymmetric unit (Table 1).
The overall structure of sc-gAd shows a tightly packed bell-
shaped trimer, with each individual gAd adopting a typical 10-
strand jelly-roll fold, resembling other C1q-like members and the
tumor necrosis factor (TNF) family proteins (Fig. 2). The b sheets
in the jelly-roll fold are arranged in two 5-strand layers, with the
inner b-strands packed tightly together. The majority of the protein
is well ordered with excellent electron density, except the N-termi-
nal 4 residues, part of b1/b2 and b9/b10 loops, and the N-terminal
5 residues from the third gAd domain were disordered. The
ig. 3. Calcium binding in sc-gAd. (A) the Fo–Fc difference electron density map (in
reen) contoured at 5.0 r for three calcium atoms. The color scheme is the same as
Fig. 1B. (B) the coordination interactions of three calcium ions in sc-gAd. (C)
etailed interactions for each individual calcium ion.
Fig. 2. Overall structure of sc-gAd in ribbon cartoon representation. The three gAd
domains are colored in the same scheme as in Fig. 1B. Calcium ions are show as
silver spheres. The disordered linker between domain 2 and 3 is shown as a dashed
line.
914 X. Min et al. / FEBS Letters 586 (2012) 912–917electron density of the main chain atoms for the N-terminal resi-
dues Pro104 to Tyr109 of the second gAd domain is clearly visible,
leaving no gap between the ﬁrst gAd and the second gAd domains.
Note that due to the high symmetry of the trimer assembly and
disorder in one of the two linker regions, the assignment of the
1st, 2nd and 3rd gAd in the primary sequence is somewhat arbi-
trary. Here, the three monomeric domains are designated as A, B
and C with a missing linker peptide between domains B and C.
Alternatively, the missing linker peptide could be between
domains A and B.
3.2. Calcium binding
Three strong positive electron density spheres in the difference
map were identiﬁed around the apex region (Fig. 3A). Based on the
octahedral coordination geometry, the bond lengths and other
related structures from collagen X NC1 domain and C1q globular
domain [28,29], these peaks were assigned as calcium. Impor-
tantly, these calcium atoms are intrinsic to sc-gAd as calcium
was never added explicitly during the puriﬁcation and crystalliza-
tion processes. Each calcium atom possesses a perfect octahedral
coordination system with neighboring oxygen atoms. The dis-
tances between the calcium atoms and surrounding oxygen atoms
are between 2.29 and 2.56 Å, in line with the coordination distance
and geometry between calcium and oxygen atoms [30]. In the ﬁnal
reﬁned structure, both the electron density maps and the temper-
ature factors suggest likely correct modeling of calcium in the apex
region.
The calcium atoms are located at the interface of adjacent
domains with each of them coordinating to two neighboring gAd
domains (Fig. 3B). They possess a perfect threefold symmetry such
that each calcium ion is coordinated by bridging two carboxylate
atoms of Asp195 in b8 strand from adjacent domains, and each
Asp195 coordinates with two calcium ions (Fig. 3B). For each cal-
cium ion, three of the coordination ligands are the carboxylate
groups of Asp187 and Asp195, and main chain carbonyl of
Gln188 from the ﬁrst gAd (domain A), while the other three areF
g
in
dfrommain chain carbonyl of Val194, and side chains of Asn193 and
Asp195 of the second gAd (domain B) (Fig. 3C). The positions of
these three calcium ions are nearly identical to those found in
the structure of Collagen X NC1 protein (PDB code: 1GR3). How-
ever, the detailed metal–ligand coordination interactions are
rather different between these two structures. In Collagen X NC1
protein, each calcium ion which also bridges two subunits is
coordinating with the carboxylate groups of three aspartate resi-
dues, two main chain carbonyls and one water molecule.
Fig. 4. Structural comparison with mouse adiponectin. (A) and (B) superposition of sc-gAd with mouse adiponectin in the absence of calcium (PDB code: 1C28). The mouse
ACRP30 is shown in green. (C) and (D) superposition of sc-gAd with mouse adiponectin in the presence of calcium (PDB code: 1C3H). Mouse adiponectin is colored wheat and
its calcium atoms are shown as red spheres.
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To our knowledge, there is no previously reported structure for
human adiponectin. The sequence identity in the globular domain
between mouse and human adiponectin is 91%. When compared to
the previously published crystal structure of mouse adiponectin
(ACRP30) (PDB code: 1C28) [31], sc-gAd reveals a very similar
overall fold, with a r.m.s.d. of 1.23 Å from alignment of 311 resi-
dues for all three domains. While the base regions of the human
and mouse gAds superpose quite well, the apex region and several
loops, including the b1/b2, b5/b6, b7/b8 and b9/b10 loop and b8
strand, show substantial movements (Fig. 4A and B). Note, the
mouse structure was determined from anEscherichia coli expressed
protein and no calcium ions were observed in the structure. The
differences observed between human sc-gAd and mouse ACRP30,
especially in the apex region, mostly result from calcium binding
in the human structure. For example, the bound calcium ions in
the human sc-gAd bring b8 strands from all three domains toward
the center of the trimer, in addition to ordering of b7/b8 loops
when compared with the mouse structure in the absence of
calcium (Fig. 4B). Calcium binding, apparently, results in a more
‘‘closed’’ conformation for the apex region in the trimeric assembly,
as opposed to disordered apical loops in the absence of calcium
apparent in the mouse structure.Another mouse adiponectin structure was deposited in the
RCSB protein data bank (PDB code: 1C3H) from the same group
who ﬁrst reported 1C28. This structure, lacking a literature refer-
ence, showed two independent gAd trimers per asymmetric unit.
Interestingly, only one trimer was complexed with three calcium
ions and the other without. While we do not have all the experi-
mental details, the calcium ions observed in one of the two trimers
were likely introduced to the protein from the crystallization buf-
fer that contained 20 mM CaCl2. When we compared our human
sc-gAd to the calcium bound mouse ACRP30 structure, the two
structures overlaid very well with a r.m.s.d of 0.58 Å from align-
ment of 386 residues. The only noticeable differences are in the
b1/b2 and b9/b10 loop regions (Fig. 4C and D). The calcium binding
attributes, including the calcium position and their coordinating
interactions, are almost identical as compared with our human
sc-gAd. While it is unclear if the calcium bound state observed in
the deposited structure of mouse adiponectin from E. coli expres-
sion is a crystallographic artifact, the structure from a mammalian
cell-expressed and active human sc-gAd indicates that the calcium
bound form is most likely a functional relevant form. This similar-
ity suggests a conserved function of calcium binding to facilitate
conformational re-arrangement of the apical loops. Indeed, the
three domains of human sc-gAd bury a total of 3483 Å2 of solvent
accessible surface area, in agreement to the buried surface area of
916 X. Min et al. / FEBS Letters 586 (2012) 912–9173415 Å2 in the ACRP30-Ca complex structure. This represents a ca.
900 Å2 increase in the buried surface area compared to the ACRP30
structure in the absence of calcium (2569 Å2).
4. Discussion
Adiponectin has the potential to be a novel therapeutic agent to
combat obesity and type II diabetes. However, production of cor-
rectly-assembled active protein remains a challenge. In addition,
many commonly used strategies for in vivo half life extension of
therapeutic proteins employ a fusion protein to the terminus of
the target protein, which aggravates the difﬁculties for generating
active fusion adiponectin protein in a homotrimeric form. Our
strategy to engineer a single-chain trimer represents a novel
approach to overcome these problems. The sc-gAd design facili-
tates the trimer formation as well as reducing the fusion partners
from 3 to 1 per trimeric protomer. We demonstrated in a separate
study that an Fc-sc-gAd fusion protein had a long half life in vivo
and maintained a similar pharmacological proﬁle as native protein
[21]. Here, the crystal structure of sc-gAd reveals that the architec-
ture of human sc-gAd is almost identical to that of the calcium
bound mouse ACRP30 globular domain. Taken together, these val-
idate our single-chain strategy for generating a functional adipo-
nectin protein.
The intrinsic calcium binding revealed by the crystal structure
of sc-gAd presents an interesting notion for adiponectin. Calcium
was previously shown to play an important role in the formation
of high molecular weight oligomers of adiponectin, which was sug-
gested to be associated with the biological function [32]. More
recent data also suggested that adiponectin and its receptor Adi-
poR1 signal through calcium and AMPK/SIRT1 pathways [33]. Gi-
ven the fact that the calcium bound sc-gAd generated here
adopts a ‘‘closed’’ apex conformation and is functional [21], we
speculate that calcium binding might play a critical role in the
assembly of active adiponectin. The bound calcium ions induce
the re-arrangement of the apical loops to form a more tightly
packed trimer protomer. It is also possible that the ‘‘closed’’ confor-
mation in the apex region induced by the calcium binding is a pre-
requisite for the formation of high molecular weight species.
Sequence analysis of adiponectin family proteins across different
species shows that the ﬁve calcium chelating residues, Asp187,
Gln188, Asn193, Asp195 and Val197, are completely conserved,
even though the overall sequence identity to human protein varies
from 84% (mouse) to 57% (zebraﬁsh). This suggests that the cal-
cium binding might be an evolutionary conserved event for adipo-
nectin. The structural role of these calcium ions in the apex region
unquestionably increases the overall protein stability and reduces
the potential susceptible proteolysis through those otherwise
disordered apex loops. Further studies such as site-directed muta-
genesis on the calcium chelating residues are needed to investigate
the ultimate function of calcium binding.
Database ID
The coordinates of the crystal structure have been deposited
with the RCSB Protein Data Bank under the accession code of 4DOU.
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